HIV-related thrombotic thrombocytopenic purpura (TTP) as first clinical manifestation of infection

III Medical Department, Fatebenefratelli-Oftalmico Hospital, Milan, Italy.
Haematologica (Impact Factor: 5.81). 01/1994; 79(3):277-9.
Source: PubMed


A case of thrombotic thrombocytopenic purpura (TTP) in a 40-year-old bisexual man unaware of being HIV positive is reported. The hematologic syndrome represented the first clinical manifestation of this viral infection. The clinical picture, characterized by severe hemolytic microangiopathic anemia, thrombocytopenia, fluctuating neurologic abnormalities and fever, quickly improved after plasma exchange and corticosteroid therapy. Two blood tests showed severe depletion of the CD4+ lymphocyte count and HIV antigenemia was positive. This case represents a clinical epiphenomenon of HIV infection in an advanced phase. According to recent CDC criteria the patient should be considered in AIDS. Antiretroviral treatment was started and after nine months of follow-up there has been no relapse.

20 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Thrombotic thrombocytopenic purpura (TTP) is a rare but well-described complication of HIV infection, which occurs equally frequently during the early asymptomatic phase of HIV infection and with clinical AIDS. The clinical spectrum varies from a low-grade asymptomatic thrombocytopenia with mild renal insufficiency to a catastrophic illness with gross neurological deficits and renal failure requiring dialysis. We report two cases of TTP associated with HIV infection seen in our institution over a period of 2 years. The clinical course of these two patients highlights the markedly heterogeneous characteristics of patients with HIV-related TTP. HIV infection may be the most common association of TTP in certain communities with a high prevalence of HIV infection. As early diagnosis and institution of plasmapheresis is crucial for a favorable outcome it is important to be aware of this association.
    AIDS PATIENT CARE and STDs 01/1997; 10(6):349-52. DOI:10.1089/apc.1996.10.349 · 3.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute renal failure (ARF) occurs in many critically ill patients regardless of age. A combination of events often seen in critical care settings, including shock, sepsis, hypoxia, and the use of potentially nephrotoxic medications, combine to make ARF an ongoing and important management issue in critical care medicine. Since the events leading to the development of ARF differ in infants, children, adults, and the elderly, the pathophysiology, clinical features, and treatment modalities do indeed have remarkable similarities among the different age groups.
    Critical Care Clinics 08/1997; 13(3):575-90. DOI:10.1016/S0749-0704(05)70329-8 · 2.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Thrombotic thrombocytopenic purpura (TTP) is a syndrome characterised by the clinical pentad of microangiopathic haemolytic anaemia (MAHA), thrombocytopenia, renal failure, fluctuating neurologic signs, and fever. The aetiology of TTP is unknown, but associations with various underlying diseases, infections and drugs have been identified. One of these associations is with HIV infection. We describe the clinical picture, the laboratory results and the response to plasma therapy of two cases of HIV-associated TTP. In both patients, a longitudinal semiquantitative assessment of the numbers of schistocytes in blood was made, which correlated well with the more traditional parameters of disease activity. Since 1987, at least 49 patients with HIV-associated TTP have been reported. A case-analysis of the 38 patients who were described in sufficient detail and a review of the literature in the setting of HIV infection is presented. The most important conclusions from these combined data are: (1) TTP usually seems to occur in patients with a CD4+ lymphocyte count < 250 x 10(6).l(-1); (2) more than 50% of the patients present with TTP soon after or during an infectious or malignant disease; (3) plasma exchange is the therapy of choice, still resulting in mortality of 22%; (4) higher initial platelet count and creatinine level are correlated with an adverse outcome.
    The Netherlands Journal of Medicine 09/1997; 51(3):103-9. DOI:10.1016/S0300-2977(97)00027-2 · 1.97 Impact Factor
Show more

Similar Publications


20 Reads